CHICAGO- Acai berry, cumin, herbal tea, turmeric and long-term use of garlic – all herbal supplements commonly believed to be beneficial to your health – may negatively impact chemotherapy treatment according to a new report presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago this summer. Researchers from Northwestern Memorial hospital say there is growing evidence that these popular supplements may intensify or weaken the effect of chemotherapy drugs and in some cases, may cause a toxic, even lethal reaction.
"With the growth of the Internet, patients have better access to information about alternative products and often turn to dietary and herbal supplements to treat their illness because they think they're natural and safe," said June M. McKoy, MD, geriatrician at Northwestern Memorial Hospital and lead investigator on the ASCO presentation. "What people don't realize is that supplements are more than just vitamins and can counteract medical therapies if not taken appropriately".
McKoy, who is also director of geriatric oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, says more research is needed to understand which supplements interact with chemotherapy drugs and the extent of those interactions and encourages patients to openly communicate with their physicians about the use of supplements.
"Patients need to tell their doctors what medications they are taking – including vitamins and supplements – to avoid any possible interaction," said McKoy who is also an assistant professor of medicine and preventive medicine at Northwestern University Feinberg School of Medicine.
Herbal supplements, defined as plant or plant parts used for therapeutic purposes, can interact with chemotherapy drugs through different mechanisms. Some herbs can interfere with the metabolism of the drugs, making them less effective while other herbs such as long-term use of garlic may increase the risk of bleeding during surgery. While culinary herbs used in small quantities for flavoring are generally safe, consuming large amounts for prolonged periods of time may have a negative effect on the body when going through chemotherapy.
Recent research shows that 50 percent of patients undergoing chemotherapy did not tell their doctor they were taking alternative therapies. "Some believe it's not important, while others are uncomfortable admitting they are pursuing alternative therapies," said McKoy. "The truth is, integrative approaches can be beneficial for cancer patients, but it's important to take these approaches at the right time and under the supervision of your doctor."
McKoy urges patients to stop taking herbal supplements while receiving chemotherapy until more is known about possible interactions, but encourages those who are interested in complementary approaches to have a conversation with their doctor about other approaches that may be beneficial.
"Integrative therapies such as massage, acupuncture and meditation can address important patient needs by alleviating stress, addressing pain and helping patients cope," said Melinda Ring, MD, medical director for the Northwestern Memorial Physicians Group's Center for Integrative Medicine and Wellness.
No matter the course of treatment, McKoy stresses the importance of physicians and patients being more cognizant of this potential interaction and encourages communication about all herbal supplement intakes. "Patients should bring in labels and bottles to their appointments. This can help the doctor calibrate drug dosage with other supplements in mind in order to prevent toxicities," stated McKoy.
McKoy plans to launch a pilot study this fall to examine how frequently conversations about supplements come up between cancer patients and their doctors.
"By identifying communication barriers, we can take steps to improve doctor patient communication in order to prevent potentially dangerous drug interactions," said McKoy.
For more information please visit www.nmh.org or call 312-926-0779.
About Northwestern Memorial HealthCare
Northwestern Memorial HealthCare is the parent corporation of Chicago's Northwestern Memorial Hospital, an 854-bed academic medical center hospital and Northwestern Lake Forest Hospital, a 205-bed community hospital located in Lake Forest, Illinois.
About Northwestern Memorial Hospital
Northwestern Memorial is one of the country's premier academic medical center hospitals and is the primary teaching hospital of the Northwestern University Feinberg School of Medicine. Along with its Prentice Women's Hospital and Stone Institute of Psychiatry, the hospital comprises 854 beds, 1,603 affiliated physicians and 7,144 employees. Northwestern Memorial is recognized for providing exemplary patient care and state-of-the art advancements in the areas of cardiovascular care; women's health; oncology; neurology and neurosurgery; solid organ and soft tissue transplants and orthopaedics.
Northwestern Memorial possesses nursing Magnet Status, the nation's highest recognition for patient care and nursing excellence. It is also listed in 13 clinical specialties in U.S. News & World Report's 2011 "America's Best Hospitals" guide and ranks No. 1 in Chicago in the 2011 U.S. News & World Report Best Hospitals metro area rankings. For 10 years running, Northwestern Memorial has been rated among the "100 Best Companies for Working Mothers" guide by Working Mother magazine. The hospital is a recipient of the prestigious National Quality Health Care Award and has been chosen by Chicagoans as the Consumer Choice according to the National Research Corporation's annual survey for 11 years.